Reuters logo
8 months ago
BRIEF-Akili and Pfizer present positive data from digital biomarker study
December 9, 2016 / 4:53 PM / 8 months ago

BRIEF-Akili and Pfizer present positive data from digital biomarker study

1 Min Read

Dec 9 (Reuters) - Akili Interactive Labs Inc:

* No safety concerns were reported during digital biomarker study

* Co's proprietary technology platform detected statistically significant difference between subjects with, without brain amyloidosis

* Akili and Pfizer present positive data from digital biomarker study to detect subtle cognitive changes in healthy subjects at risk of developing Alzheimer's disease Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below